FDC Limited has announced to the exchanges regarding receipt of ANDA approval for Ofloxacin Otic Solution, 0.3%.
In a regulatory filing, the company said that it has been granted ANDA approval by United States Food and Drug Administration (U.S. FDA), for Ofloxacin Otic Solution, 0.3%.
The Company is mainly engaged in manufacture of specialized formulations, and oral rehydration salts (ORS).
On Monday morning trade, FDC stock was trading at Rs287 per piece higher by 0.65% on Sensex.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.